Sign inJoin waitlistJoin the waitlist

Kathleen Harnden

Medical Oncologist · Inova Fair Oaks Hospital

Credentials: · · ·

History

Inova Fair Oaks Hospital
Present

Hematology and Medical Oncology
Duke University Hospital
2013–2016
Internal Medicine
Duke University Hospital
2008–2011
University of Virginia Darden School of Business
University of Southern California School of Medicine
2006–2010

Research

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced…
Journal of Clinical Oncology · 2022 · 629 citations
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor…
Journal of Clinical Oncology · 2024 · 45 citations
Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?
BMC Medicine · 2014 · 34 citations

Aditya Bardia
3 papers
Ana Barac
3 papers
KB
Kimberly Blackwell
3 papers
Lauren Mauro
3 papers
Angela Pennisi
2 papers
Ajay Dhakal
1 paper
Alberto Montero
1 paper
Alissa Marr
1 paper
Angela Jain
1 paper
Anu Gaba
1 paper
Charles Leath
1 paper
CM
Cynthia Ma
1 paper